Global Avian Influenza Vaccines Sales Market Report 2021

Publisher Name :
Date: 06-Apr-2021
No. of pages: 139
Inquire Before Buying

The global Avian Influenza Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Avian Influenza Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type

- Type H5

- Type H9

- Other

Segment by Application

- Chicken

- Duck & Goose

- Other

The Avian Influenza Vaccines market is analysed and market size information is provided by regions (countries). Segment by Application, the Avian Influenza Vaccines market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company

- Merial

- CEVA

- Zoetis

- Elanco (Lohmann )

- Merck Animal Health

- Avimex Animal Health

Global Avian Influenza Vaccines Sales Market Report 2021

Table of Contents
1 Avian Influenza Vaccines Market Overview
1.1 Avian Influenza Vaccines Product Scope
1.2 Avian Influenza Vaccines Segment by Type
1.2.1 Global Avian Influenza Vaccines Sales by Type (2016 & 2021 & 2027)
1.2.2 Type H5
1.2.3 Type H9
1.2.4 Other
1.3 Avian Influenza Vaccines Segment by Application
1.3.1 Global Avian Influenza Vaccines Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Chicken
1.3.3 Duck & Goose
1.3.4 Other
1.4 Avian Influenza Vaccines Market Estimates and Forecasts (2016-2027)
1.4.1 Global Avian Influenza Vaccines Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Avian Influenza Vaccines Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Avian Influenza Vaccines Price Trends (2016-2027)
2 Avian Influenza Vaccines Estimates and Forecasts by Region
2.1 Global Avian Influenza Vaccines Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Avian Influenza Vaccines Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Avian Influenza Vaccines Sales Market Share by Region (2016-2021)
2.2.2 Global Avian Influenza Vaccines Revenue Market Share by Region (2016-2021)
2.3 Global Avian Influenza Vaccines Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Avian Influenza Vaccines Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Avian Influenza Vaccines Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Avian Influenza Vaccines Estimates and Projections (2016-2027)
2.4.2 Europe Avian Influenza Vaccines Estimates and Projections (2016-2027)
2.4.3 China Avian Influenza Vaccines Estimates and Projections (2016-2027)
2.4.4 Japan Avian Influenza Vaccines Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Avian Influenza Vaccines Estimates and Projections (2016-2027)
2.4.6 India Avian Influenza Vaccines Estimates and Projections (2016-2027)
3 Global Avian Influenza Vaccines Competition Landscape by Players
3.1 Global Top Avian Influenza Vaccines Players by Sales (2016-2021)
3.2 Global Top Avian Influenza Vaccines Players by Revenue (2016-2021)
3.3 Global Avian Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Avian Influenza Vaccines as of 2020)
3.4 Global Avian Influenza Vaccines Average Price by Company (2016-2021)
3.5 Manufacturers Avian Influenza Vaccines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Avian Influenza Vaccines Market Size by Type
4.1 Global Avian Influenza Vaccines Historic Market Review by Type (2016-2021)
4.1.1 Global Avian Influenza Vaccines Sales Market Share by Type (2016-2021)
4.1.2 Global Avian Influenza Vaccines Revenue Market Share by Type (2016-2021)
4.1.3 Global Avian Influenza Vaccines Price by Type (2016-2021)
4.2 Global Avian Influenza Vaccines Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Avian Influenza Vaccines Sales Forecast by Type (2022-2027)
4.2.2 Global Avian Influenza Vaccines Revenue Forecast by Type (2022-2027)
4.2.3 Global Avian Influenza Vaccines Price Forecast by Type (2022-2027)
5 Global Avian Influenza Vaccines Market Size by Application
5.1 Global Avian Influenza Vaccines Historic Market Review by Application (2016-2021)
5.1.1 Global Avian Influenza Vaccines Sales Market Share by Application (2016-2021)
5.1.2 Global Avian Influenza Vaccines Revenue Market Share by Application (2016-2021)
5.1.3 Global Avian Influenza Vaccines Price by Application (2016-2021)
5.2 Global Avian Influenza Vaccines Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Avian Influenza Vaccines Sales Forecast by Application (2022-2027)
5.2.2 Global Avian Influenza Vaccines Revenue Forecast by Application (2022-2027)
5.2.3 Global Avian Influenza Vaccines Price Forecast by Application (2022-2027)
6 North America Avian Influenza Vaccines Market Facts & Figures
6.1 North America Avian Influenza Vaccines Sales by Company
6.1.1 North America Avian Influenza Vaccines Sales by Company (2016-2021)
6.1.2 North America Avian Influenza Vaccines Revenue by Company (2016-2021)
6.2 North America Avian Influenza Vaccines Sales Breakdown by Type
6.2.1 North America Avian Influenza Vaccines Sales Breakdown by Type (2016-2021)
6.2.2 North America Avian Influenza Vaccines Sales Breakdown by Type (2022-2027)
6.3 North America Avian Influenza Vaccines Sales Breakdown by Application
6.3.1 North America Avian Influenza Vaccines Sales Breakdown by Application (2016-2021)
6.3.2 North America Avian Influenza Vaccines Sales Breakdown by Application (2022-2027)
7 Europe Avian Influenza Vaccines Market Facts & Figures
7.1 Europe Avian Influenza Vaccines Sales by Company
7.1.1 Europe Avian Influenza Vaccines Sales by Company (2016-2021)
7.1.2 Europe Avian Influenza Vaccines Revenue by Company (2016-2021)
7.2 Europe Avian Influenza Vaccines Sales Breakdown by Type
7.2.1 Europe Avian Influenza Vaccines Sales Breakdown by Type (2016-2021)
7.2.2 Europe Avian Influenza Vaccines Sales Breakdown by Type (2022-2027)
7.3 Europe Avian Influenza Vaccines Sales Breakdown by Application
7.3.1 Europe 139 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 139 Sales Breakdown by Application (2022-2027)
8 China Avian Influenza Vaccines Market Facts & Figures
8.1 China Avian Influenza Vaccines Sales by Company
8.1.1 China Avian Influenza Vaccines Sales by Company (2016-2021)
8.1.2 China Avian Influenza Vaccines Revenue by Company (2016-2021)
8.2 China Avian Influenza Vaccines Sales Breakdown by Type
8.2.1 China Avian Influenza Vaccines Sales Breakdown by Type (2016-2021)
8.2.2 China Avian Influenza Vaccines Sales Breakdown by Type (2022-2027)
8.3 China Avian Influenza Vaccines Sales Breakdown by Application
8.3.1 China 240 Sales Breakdown by Application (2016-2021)
8.3.2 China 240 Sales Breakdown by Application (2022-2027)
9 Japan Avian Influenza Vaccines Market Facts & Figures
9.1 Japan Avian Influenza Vaccines Sales by Company
9.1.1 Japan Avian Influenza Vaccines Sales by Company (2016-2021)
9.1.2 Japan Avian Influenza Vaccines Revenue by Company (2016-2021)
9.2 Japan Avian Influenza Vaccines Sales Breakdown by Type
9.2.1 Japan Avian Influenza Vaccines Sales Breakdown by Type (2016-2021)
9.2.2 Japan Avian Influenza Vaccines Sales Breakdown by Type (2022-2027)
9.3 Japan Avian Influenza Vaccines Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Avian Influenza Vaccines Market Facts & Figures
10.1 Southeast Asia Avian Influenza Vaccines Sales by Company
10.1.1 Southeast Asia Avian Influenza Vaccines Sales by Company (2016-2021)
10.1.2 Southeast Asia Avian Influenza Vaccines Revenue by Company (2016-2021)
10.2 Southeast Asia Avian Influenza Vaccines Sales Breakdown by Type
10.2.1 Southeast Asia Avian Influenza Vaccines Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Avian Influenza Vaccines Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Avian Influenza Vaccines Sales Breakdown by Application
10.3.1 Southeast Asia M Doses Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M Doses Sales Breakdown by Application (2022-2027)
11 India Avian Influenza Vaccines Market Facts & Figures
11.1 India Avian Influenza Vaccines Sales by Company
11.1.1 India Avian Influenza Vaccines Sales by Company (2016-2021)
11.1.2 India Avian Influenza Vaccines Revenue by Company (2016-2021)
11.2 India Avian Influenza Vaccines Sales Breakdown by Type
11.2.1 India Avian Influenza Vaccines Sales Breakdown by Type (2016-2021)
11.2.2 India Avian Influenza Vaccines Sales Breakdown by Type (2022-2027)
11.3 India Avian Influenza Vaccines Sales Breakdown by Application
11.3.1 India Avian Influenza Vaccines Sales Breakdown by Application (2016-2021)
11.3.2 India Avian Influenza Vaccines Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Avian Influenza Vaccines Business
12.1 Merial
12.1.1 Merial Corporation Information
12.1.2 Merial Business Overview
12.1.3 Merial Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Merial Avian Influenza Vaccines Products Offered
12.1.5 Merial Recent Development
12.2 CEVA
12.2.1 CEVA Corporation Information
12.2.2 CEVA Business Overview
12.2.3 CEVA Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.2.4 CEVA Avian Influenza Vaccines Products Offered
12.2.5 CEVA Recent Development
12.3 Zoetis
12.3.1 Zoetis Corporation Information
12.3.2 Zoetis Business Overview
12.3.3 Zoetis Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Zoetis Avian Influenza Vaccines Products Offered
12.3.5 Zoetis Recent Development
12.4 Elanco (Lohmann )
12.4.1 Elanco (Lohmann ) Corporation Information
12.4.2 Elanco (Lohmann ) Business Overview
12.4.3 Elanco (Lohmann ) Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Elanco (Lohmann ) Avian Influenza Vaccines Products Offered
12.4.5 Elanco (Lohmann ) Recent Development
12.5 Merck Animal Health
12.5.1 Merck Animal Health Corporation Information
12.5.2 Merck Animal Health Business Overview
12.5.3 Merck Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Merck Animal Health Avian Influenza Vaccines Products Offered
12.5.5 Merck Animal Health Recent Development
12.6 Avimex Animal Health
12.6.1 Avimex Animal Health Corporation Information
12.6.2 Avimex Animal Health Business Overview
12.6.3 Avimex Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Avimex Animal Health Avian Influenza Vaccines Products Offered
12.6.5 Avimex Animal Health Recent Development
...
13 Avian Influenza Vaccines Manufacturing Cost Analysis
13.1 Avian Influenza Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Avian Influenza Vaccines
13.4 Avian Influenza Vaccines Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Avian Influenza Vaccines Distributors List
14.3 Avian Influenza Vaccines Customers
15 Market Dynamics
15.1 Avian Influenza Vaccines Market Trends
15.2 Avian Influenza Vaccines Drivers
15.3 Avian Influenza Vaccines Market Challenges
15.4 Avian Influenza Vaccines Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Avian Influenza Vaccines Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Avian Influenza Vaccines Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Avian Influenza Vaccines Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Avian Influenza Vaccines Sales (M Doses) by Region (2016-2021)
Table 5. Global Avian Influenza Vaccines Sales Market Share by Region (2016-2021)
Table 6. Global Avian Influenza Vaccines Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Avian Influenza Vaccines Revenue Share by Region (2016-2021)
Table 8. Global Avian Influenza Vaccines Sales (M Doses) Forecast by Region (2022-2027)
Table 9. Global Avian Influenza Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Avian Influenza Vaccines Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Avian Influenza Vaccines Revenue Share Forecast by Region (2022-2027)
Table 12. Global Avian Influenza Vaccines Sales (M Doses) of Key Companies (2016-2021)
Table 13. Global Avian Influenza Vaccines Sales Share by Company (2016-2021)
Table 14. Global Avian Influenza Vaccines Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Avian Influenza Vaccines Revenue Share by Company (2016-2021)
Table 16. Global Avian Influenza Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Avian Influenza Vaccines as of 2020)
Table 17. Global Avian Influenza Vaccines Average Price (USD/K Doses) of Key Company (2016-2021)
Table 18. Manufacturers Avian Influenza Vaccines Manufacturing Sites and Area Served
Table 19. Manufacturers Avian Influenza Vaccines Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Avian Influenza Vaccines Sales (M Doses) by Type (2016-2021)
Table 22. Global Avian Influenza Vaccines Sales Share by Type (2016-2021)
Table 23. Global Avian Influenza Vaccines Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Avian Influenza Vaccines Price (USD/K Doses) by Type (2016-2021)
Table 25. Global Avian Influenza Vaccines Sales Share by Type (2022-2027)
Table 26. Global Avian Influenza Vaccines Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Avian Influenza Vaccines Revenue Share by Type (2022-2027)
Table 28. Global Avian Influenza Vaccines Price (USD/K Doses) by Type (2022-2027)
Table 29. Global Avian Influenza Vaccines Sales (M Doses) by Application (2016-2021)
Table 30. Global Avian Influenza Vaccines Sales Share by Application (2016-2021)
Table 31. Global Avian Influenza Vaccines Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Avian Influenza Vaccines Price (USD/K Doses) by Application (2016-2021)
Table 33. Global Avian Influenza Vaccines Sales (M Doses) by Application (2022-2027)
Table 34. Global Avian Influenza Vaccines Sales Share by Application (2022-2027)
Table 35. Global Avian Influenza Vaccines Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Avian Influenza Vaccines Revenue Share by Application (2022-2027)
Table 37. Global Avian Influenza Vaccines Price (USD/K Doses) by Application (2022-2027)
Table 38. North America Avian Influenza Vaccines Sales (M Doses) by Company (2016-2021)
Table 39. North America Avian Influenza Vaccines Sales Market Share by Company (2016-2021)
Table 40. North America Avian Influenza Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Avian Influenza Vaccines Revenue Market Share by Company (2016-2021)
Table 42. North America Avian Influenza Vaccines Sales by Type (2016-2021) & (M Doses)
Table 43. North America Avian Influenza Vaccines Sales Market Share by Type (2016-2021)
Table 44. North America Avian Influenza Vaccines Sales by Type (2022-2027) & (M Doses)
Table 45. North America Avian Influenza Vaccines Sales Market Share by Type (2022-2027)
Table 46. North America Avian Influenza Vaccines Sales by Application (2016-2021) & (M Doses)
Table 47. North America Avian Influenza Vaccines Sales Market Share by Application (2016-2021)
Table 48. North America Avian Influenza Vaccines Sales by Application (2022-2027) & (M Doses)
Table 49. North America Avian Influenza Vaccines Sales Market Share by Application (2022-2027)
Table 50. Europe Avian Influenza Vaccines Sales (M Doses) by Company (2016-2021)
Table 51. Europe Avian Influenza Vaccines Sales Market Share by Company (2016-2021)
Table 52. Europe Avian Influenza Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Avian Influenza Vaccines Revenue Market Share by Company (2016-2021)
Table 54. Europe Avian Influenza Vaccines Sales by Type (2016-2021) & (M Doses)
Table 55. Europe Avian Influenza Vaccines Sales Market Share by Type (2016-2021)
Table 56. Europe Avian Influenza Vaccines Sales by Type (2022-2027) & (M Doses)
Table 57. Europe Avian Influenza Vaccines Sales Market Share by Type (2022-2027)
Table 58. Europe Avian Influenza Vaccines Sales by Application (2016-2021) & (M Doses)
Table 59. Europe Avian Influenza Vaccines Sales Market Share by Application (2016-2021)
Table 60. Europe Avian Influenza Vaccines Sales by Application (2022-2027) & (M Doses)
Table 61. Europe Avian Influenza Vaccines Sales Market Share by Application (2022-2027)
Table 62. China Avian Influenza Vaccines Sales (M Doses) by Company (2016-2021)
Table 63. China Avian Influenza Vaccines Sales Market Share by Company (2016-2021)
Table 64. China Avian Influenza Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Avian Influenza Vaccines Revenue Market Share by Company (2016-2021)
Table 66. China Avian Influenza Vaccines Sales by Type (2016-2021) & (M Doses)
Table 67. China Avian Influenza Vaccines Sales Market Share by Type (2016-2021)
Table 68. China Avian Influenza Vaccines Sales by Type (2022-2027) & (M Doses)
Table 69. China Avian Influenza Vaccines Sales Market Share by Type (2022-2027)
Table 70. China Avian Influenza Vaccines Sales by Application (2016-2021) & (M Doses)
Table 71. China Avian Influenza Vaccines Sales Market Share by Application (2016-2021)
Table 72. China Avian Influenza Vaccines Sales by Application (2022-2027) & (M Doses)
Table 73. China Avian Influenza Vaccines Sales Market Share by Application (2022-2027)
Table 74. Japan Avian Influenza Vaccines Sales (M Doses) by Company (2016-2021)
Table 75. Japan Avian Influenza Vaccines Sales Market Share by Company (2016-2021)
Table 76. Japan Avian Influenza Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Avian Influenza Vaccines Revenue Market Share by Company (2016-2021)
Table 78. Japan Avian Influenza Vaccines Sales by Type (2016-2021) & (M Doses)
Table 79. Japan Avian Influenza Vaccines Sales Market Share by Type (2016-2021)
Table 80. Japan Avian Influenza Vaccines Sales by Type (2022-2027) & (M Doses)
Table 81. Japan Avian Influenza Vaccines Sales Market Share by Type (2022-2027)
Table 82. Japan Avian Influenza Vaccines Sales by Application (2016-2021) & (M Doses)
Table 83. Japan Avian Influenza Vaccines Sales Market Share by Application (2016-2021)
Table 84. Japan Avian Influenza Vaccines Sales by Application (2022-2027) & (M Doses)
Table 85. Japan Avian Influenza Vaccines Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Avian Influenza Vaccines Sales (M Doses) by Company (2016-2021)
Table 87. Southeast Asia Avian Influenza Vaccines Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Avian Influenza Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Avian Influenza Vaccines Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Avian Influenza Vaccines Sales by Type (2016-2021) & (M Doses)
Table 91. Southeast Asia Avian Influenza Vaccines Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Avian Influenza Vaccines Sales by Type (2022-2027) & (M Doses)
Table 93. Southeast Asia Avian Influenza Vaccines Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Avian Influenza Vaccines Sales by Application (2016-2021) & (M Doses)
Table 95. Southeast Asia Avian Influenza Vaccines Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Avian Influenza Vaccines Sales by Application (2022-2027) & (M Doses)
Table 97. Southeast Asia Avian Influenza Vaccines Sales Market Share by Application (2022-2027)
Table 98. India Avian Influenza Vaccines Sales (M Doses) by Company (2016-2021)
Table 99. India Avian Influenza Vaccines Sales Market Share by Company (2016-2021)
Table 100. India Avian Influenza Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Avian Influenza Vaccines Revenue Market Share by Company (2016-2021)
Table 102. India Avian Influenza Vaccines Sales by Type (2016-2021) & (M Doses)
Table 103. India Avian Influenza Vaccines Sales Market Share by Type (2016-2021)
Table 104. India Avian Influenza Vaccines Sales by Type (2022-2027) & (M Doses)
Table 105. India Avian Influenza Vaccines Sales Market Share by Type (2022-2027)
Table 106. India Avian Influenza Vaccines Sales by Application (2016-2021) & (M Doses)
Table 107. India Avian Influenza Vaccines Sales Market Share by Application (2016-2021)
Table 108. India Avian Influenza Vaccines Sales by Application (2022-2027) & (M Doses)
Table 109. India Avian Influenza Vaccines Sales Market Share by Application (2022-2027)
Table 110. Merial Corporation Information
Table 111. Merial Description and Business Overview
Table 112. Merial Avian Influenza Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 113. Merial Avian Influenza Vaccines Product
Table 114. Merial Recent Development
Table 115. CEVA Corporation Information
Table 116. CEVA Description and Business Overview
Table 117. CEVA Avian Influenza Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 118. CEVA Avian Influenza Vaccines Product
Table 119. CEVA Recent Development
Table 120. Zoetis Corporation Information
Table 121. Zoetis Description and Business Overview
Table 122. Zoetis Avian Influenza Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 123. Zoetis Avian Influenza Vaccines Product
Table 124. Zoetis Recent Development
Table 125. Elanco (Lohmann ) Corporation Information
Table 126. Elanco (Lohmann ) Description and Business Overview
Table 127. Elanco (Lohmann ) Avian Influenza Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 128. Elanco (Lohmann ) Avian Influenza Vaccines Product
Table 129. Elanco (Lohmann ) Recent Development
Table 130. Merck Animal Health Corporation Information
Table 131. Merck Animal Health Description and Business Overview
Table 132. Merck Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 133. Merck Animal Health Avian Influenza Vaccines Product
Table 134. Merck Animal Health Recent Development
Table 135. Avimex Animal Health Corporation Information
Table 136. Avimex Animal Health Description and Business Overview
Table 137. Avimex Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 138. Avimex Animal Health Avian Influenza Vaccines Product
Table 139. Avimex Animal Health Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Avian Influenza Vaccines Distributors List
Table 143. Avian Influenza Vaccines Customers List
Table 144. Avian Influenza Vaccines Market Trends
Table 145. Avian Influenza Vaccines Market Drivers
Table 146. Avian Influenza Vaccines Market Challenges
Table 147. Avian Influenza Vaccines Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Avian Influenza Vaccines Product Picture
Figure 2. Global Avian Influenza Vaccines Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Avian Influenza Vaccines Sales Market Share by Application in 2021 & 2027
Figure 6. Chicken Examples
Figure 7. Duck & Goose Examples
Figure 8. Other Examples
Figure 9. Global Avian Influenza Vaccines Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Avian Influenza Vaccines Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Avian Influenza Vaccines Sales (M Doses) Growth Rate (2016-2027)
Figure 12. Global Avian Influenza Vaccines Price Trends Growth Rate (2016-2027) (USD/K Doses)
Figure 13. Global Avian Influenza Vaccines Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Avian Influenza Vaccines Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Avian Influenza Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Avian Influenza Vaccines Sales (M Doses) Growth Rate (2016-2027)
Figure 17. Europe Avian Influenza Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Avian Influenza Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Avian Influenza Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Avian Influenza Vaccines Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Avian Influenza Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Avian Influenza Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Avian Influenza Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Avian Influenza Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Avian Influenza Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Avian Influenza Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Avian Influenza Vaccines Players Market Share by Revenue in Avian Influenza Vaccines: 2016 & 2020
Figure 28. Avian Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Avian Influenza Vaccines Revenue Share by Type (2016-2021)
Figure 30. Global Avian Influenza Vaccines Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Avian Influenza Vaccines Revenue Share by Application (2016-2021)
Figure 32. Global Avian Influenza Vaccines Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Avian Influenza Vaccines Sales Market Share by Type in 2020
Figure 34. North America Avian Influenza Vaccines Sales Market Share by Application in 2020
Figure 35. Europe Avian Influenza Vaccines Sales Market Share by Type in 2020
Figure 36. Europe Avian Influenza Vaccines Sales Market Share by Application in 2020
Figure 37. China Avian Influenza Vaccines Sales Market Share by Type in 2020
Figure 38. China Avian Influenza Vaccines Sales Market Share by Application in 2020
Figure 39. Japan Avian Influenza Vaccines Sales Market Share by Type in 2020
Figure 40. Japan Avian Influenza Vaccines Sales Market Share by Application in 2020
Figure 41. Southeast Asia Avian Influenza Vaccines Sales Market Share by Type in 2020
Figure 42. Southeast Asia Avian Influenza Vaccines Sales Market Share by Application in 2020
Figure 43. India Avian Influenza Vaccines Sales Market Share by Type in 2020
Figure 44. India Avian Influenza Vaccines Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Avian Influenza Vaccines
Figure 47. Manufacturing Process Analysis of Avian Influenza Vaccines
Figure 48. Avian Influenza Vaccines Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
  • 2020-2025 Global Avian Influenza Vaccines Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
    Published: 27-Apr-2021        Price: US 3360 Onwards        Pages: 112
    Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred. This report elaborates the market size, market characteristics, and market growth of the Avian Influenza Vaccines industry, and bre......
  • Global Influenza Vaccine Sales Market Report 2021
    Published: 21-Apr-2021        Price: US 4000 Onwards        Pages: 139
    The global Influenza Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Whole Virus Vaccines - Split Virus Vaccin......
  • Global Influenza Vaccines Market 2021 - 2027
    Published: 19-Apr-2021        Price: US 3450 Onwards        Pages: 275
    The number of persons being vaccinated with influenza vaccines worldwide will touch the figure of 500 Million by the year-end of 2027 Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against influenza vaccines, the introduction of quadrivalent influenza vaccines, increase in the size of the elderly population in most of the countries. Long–term Growth Projection:......
  • Global Avian Influenza Vaccines Sales Market Report 2021
    Published: 06-Apr-2021        Price: US 4000 Onwards        Pages: 139
    The global Avian Influenza Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Avian Influenza Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Type H5 - Type H9 - ......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Report 2021
    Published: 01-Apr-2021        Price: US 4000 Onwards        Pages: 134
    The global 23-Valent Pneumococcal Polysaccharide Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global 23-Valent Pneumococcal Polysaccharide Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type......
  • Global Covid-19 Vaccine Market - Analysis By Product Type, Patient Type, End User, By Region, By Country (2021 Edition): Market Insights, Competition and Forecast (2020-2030)
    Published: 31-Mar-2021        Price: US 2000 Onwards        Pages: 214
    Executive Summary Global Covid-19 vaccine Market will be valued at approximately USD 25 billion in the year 2024. The growing government support for vaccine development and the increasing involvement of global organizations in the development of adequate vaccination facilities in endemic regions is anticipated to positively influence the sales of Coronavirus vaccine in the upcoming years. Moreover, the strong demand for coronavirus vaccine, the ongoing initiative initiatives by go......
  • 2020-2025 Global H1N1 Vaccines Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
    Published: 30-Mar-2021        Price: US 3360 Onwards        Pages: 97
    This report elaborates the market size, market characteristics, and market growth of the H1N1 Vaccines industry, and breaks down according to the type, application, and consumption area of H1N1 Vaccines. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry. In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry re......
  • 2020-2025 Global Influenza Vaccine Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
    Published: 25-Mar-2021        Price: US 3360 Onwards        Pages: 120
    Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... This report elaborates the market size, market characteristics, and market growth of the Influenza Vaccine industry, and breaks down according to the type, application, and consumption area of Influenza Vaccine. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry. In Chap......
  • Global Encephalitis Vaccination Market Growth (Status and Outlook) 2021-2026
    Published: 22-Mar-2021        Price: US 3660 Onwards        Pages: 115
    According to this latest study, the 2021 growth of Encephalitis Vaccination will have significant change from previous year. By the most conservative estimates of global Encephalitis Vaccination market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 1196.1 million in 2020. Over the next five years the Encephalitis Vaccination market will register a 5.8% CAGR in terms of revenue, the global market size will reach US$ 1499.2 million by 2026. ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs